PathAI | Pathology Transformed

Description

PathAI is at the forefront of transforming pathology through artificial intelligence. The company's mission is to improve patient outcomes by integrating AI-powered technology with meaningful collaboration among biopharma, laboratories, and clinicians. PathAI's solutions provide invaluable insights for biomarker discovery and drug development, while also enhancing laboratory workflows.

One of PathAI's flagship offerings is AISight, a cloud-native, open platform enterprise workflow solution. AISight serves as a central hub for case management, image management, and AI applications, enabling multiple histopathology use cases. It is utilized by leading laboratories and research centers worldwide to power their digital pathology workflows.

PathAI's technology is leveraged by top biopharma companies to advance drug and diagnostic development. The platform supports precision medicine by providing tools for standardized histopathology endpoints and AI-based algorithm training and validation. PathAI has also partnered with MedStar Health to deploy the AISight Dx Digital Pathology Platform and advanced AI applications.

The company has received FDA clearance for its AISight Dx Platform for primary diagnosis, and its AIM-MASH AI Assist tool is the first AI-powered tool to receive FDA qualification for MASH clinical trials. PathAI continues to expand its clinical trials platform with new offerings like AIM-HITM UC and IBDExploreTM.

PathAI is committed to solving significant challenges in healthcare and transforming pathology with AI. The company actively seeks board-certified pathologists to join its contributor network, providing pathology interpretation services for research and development efforts.

PathAI's Core Features

• AI-powered pathology

• Collaboration with biopharma

• AISight platform

• Digital pathology workflows

• Biomarker discovery

• Drug development support

• FDA-cleared platform

• Precision medicine tools

How to use PathAI?

1. 1

   Configure: Set up AISight platform

2. 2

   Use: Implement digital pathology workflows

3. 3

   Optimize: Enhance laboratory efficiency

4. 4

   Collaborate: Work with biopharma and clinicians

PathAI's Use Cases

• Biomarker Discovery
• Drug Development
• Laboratory Workflows
• Clinical Trials
• Precision Medicine

FAQ from PathAI

• What is PathAI's primary mission?

  PathAI aims to improve patient outcomes through AI-powered pathology and collaboration with biopharma and laboratories.

• What is AISight?

  AISight is a cloud-native platform for managing digital pathology workflows and AI applications.

• Who uses PathAI's technology?

  Leading laboratories, research centers, and top biopharma companies use PathAI's technology.

• What is the role of AI in PathAI's solutions?

  AI is used to enhance pathology workflows, support biomarker discovery, and aid drug development.

• Has PathAI received any FDA clearances?

  Yes, PathAI's AISight Dx Platform has received FDA clearance for primary diagnosis.

• What is AIM-MASH AI Assist?

  AIM-MASH AI Assist is an AI-powered tool qualified by the FDA for MASH clinical trials.

• How does PathAI support precision medicine?

  PathAI provides tools for standardized histopathology endpoints and AI-based algorithm training.

• What partnerships has PathAI formed?

  PathAI has partnered with MedStar Health and Labcorp to deploy its digital pathology platform.